Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001045979 | SCV001209858 | pathogenic | not provided | 2022-03-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 843369). This premature translational stop signal has been observed in individual(s) with early infantile epileptic encephalopathy (PMID: 27248490). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Arg3235*) in the SZT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SZT2 are known to be pathogenic (PMID: 23932106, 27248490, 28556953). |
Genetics Laboratory, |
RCV001420267 | SCV001622687 | pathogenic | See cases | 2021-04-26 | criteria provided, single submitter | clinical testing | PVS1_very strong;PM2_supporting;PM3_supporting;PP5_supporting |
Genome- |
RCV003457923 | SCV004178103 | pathogenic | Developmental and epileptic encephalopathy, 18 | 2023-04-11 | criteria provided, single submitter | clinical testing |